Post by
rgonlyfactspls on Jan 08, 2016 2:54pm
Try this math...
27%-18%=9% and 9%/18%= +50% (i.e., better) The drug related to the figure "27%" was just voted down at its AdCom meeting. The drug related to the figure "18%" is FDA approved. The former drug (at 27%) is also considerably more safe for patents and medical staff. Comparison is for exactly the same indication. Now bold this date on your calendar (unless HT just started his value-add countdown): FDA's PDUFE review/decision for MCNA > Feb. 27-16. Excerpts re stats: 1) "In a subpopulation of subjects with CIS-containing disease who received MCNA treatment, 27% of subjects experienced CR at 6 months that appeared to be durable without cystectomy." Source: FDA Briefing Document, pg 46. 2) Valstar clinical trial results: "In the 90 study patients with BCG-refractory carcinoma in situ (CIS), 16 patients (18%) had a complete response at 6 months." https://1.usa.gov/1O5xyFa
Comment by
ragingbull1327 on Jan 08, 2016 4:02pm
I imagine that people came up with the religious philosophies and wrote out their holy books faster than this, and that was thousands of years ago. My, we've come a long way..... Look at us goooooooo! ;)
Comment by
ragingbull1327 on Jan 08, 2016 4:31pm
I said 20 years. That's not too far away. Two "back-to-back" drug approval process for the FDA. Peanuts
Comment by
CasusRisen on Jan 08, 2016 9:32pm
This post has been removed in accordance with Community Policy
Comment by
HighteawithIntrepid on Jan 08, 2016 10:19pm
CR given that most of us have had RB on ignore for months our collective thought would be that if he ever has a rational post repost it but beyond that I will try not to post until there is some real news or we hit day 40 to go. HT